Seroprevalence of campylobacteriosis and relevant post-infectious sequelae

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 6, 2014, Pages 1019-1027

  Zautner, A E ^a   Johann, C ^a   Strubel, A ^b   Busse, C ^b   Tareen, A M ^a   Masanta, W O ^a   Lugert, R ^a   Schmidt Ott, R ^a,c   Gross U ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b SEKISUI CHEMICAL CO LTD   (Japan)

^c GSK   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAMPLOBACTER ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MOMP ANTIGEN; OMP18 ANTIGEN; P39 ANTIGEN; PEB1 ANTIGEN; PEB2 ANTIGEN; PEB4 ANTIGEN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BORRELIA AFZELII; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTERIOSIS; CELL LYSATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; WHOLE CELL; YERSINIA ENTEROCOLITICA; ADOLESCENT; ARTHRITIS, REACTIVE; BLOOD; CAMPYLOBACTER INFECTIONS; COHORT ANALYSIS; COMPLICATION; EPIDEMIOLOGY; GUILLAIN-BARRE SYNDROME; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ARTHRITIS, REACTIVE; CAMPYLOBACTER INFECTIONS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84903816004     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-2040-4     Document Type: Article

References (48)

1. Allos BM (1997) Association between Campylobacter infection and Guillain-Barre syndrome. J Infect Dis 176(Suppl 2):S125-S128
2. Nachamkin I, Allos BM, Ho T (1998) Campylobacter species and Guillain-Barre syndrome. Clin Microbiol Rev 11(3):555-567 (Pubitemid 28379100)
3. Butzler JP (2004) Campylobacter, from obscurity to celebrity. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis 10(10): 868-876
4. Dasti JI, Tareen AM, Lugert R, Zautner AE, Groß U (2010) Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol: IJMM 300(4):205-211
5. Zautner AE, Herrmann S, Groß U (2010) Campylobacter jejuni - The search for virulence-associated factors. Arch Leb 61(3):91-101
6. Schwerer B (2002) Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barre syndrome. Microbes Infect/Inst Pasteur 4(3):373-384
7. Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM (2007) Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37(1):48-55 (Pubitemid 47087887)
8. Mortensen NP, Kuijf ML, Ang CW, Schiellerup P, Krogfelt KA, Jacobs BC, van Belkum A, Endtz HP, Bergman MP (2009) Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect/Inst Pasteur 11(12):988-994
9. Townes JM (2010) Reactive arthritis after enteric infections in the United States: the problem of definition. Clin Infect Dis: Off Publ Infect Dis Soc Am 50(2):247-254
10. Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, Siitonen A, Leirisalo-Repo M (2002) Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology 41(3):312-318 (Pubitemid 34537868)
11. Garcia Rodriguez LA, Ruigomez A, Panes J (2006) Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130(6):1588-1594 (Pubitemid 43668828)
12. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H(2009) Increased short- and long-termrisk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 137(2):495-501
13. Jess T, Simonsen J, Nielsen NM, Jorgensen KT, Bager P, Ethelberg S, Frisch M (2011) Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 60(3):318-324
14. Riddle MS, Gutierrez RL, Verdu EF, Porter CK (2012) The chronic gastrointestinal consequences associated with campylobacter. Curr Gastroenterol Rep 14(5):395-405
15. Masanta WO, Heimesaat MM, Bereswill S, Tareen AM, Lugert R, Groß U, Zautner AE (2013) Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol 2013:10
16. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kuhl AA, Dasti JI, Zautner AE, Munoz M, Loddenkemper C, Groß U, Gobel UB, Heimesaat MM (2011) Novel murine infection models provide deep insights into the "menage a trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS ONE 6(6):e20953
17. Bereswill S, Plickert R, Fischer A, Khül AA, Loddenkemper C, Batra A, Siegmund B, Göbel UB, Heimesaat MM (2011) What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. Eur J Microbiol Immunol 1(3):237-248
18. Boswell TC, Kudesia G (1992) Serological cross-reaction between Legionella pneumophila and campylobacter in the indirect fluorescent antibody test. Epidemiol Infect 109(2):291-295
19. Colmegna I, Cuchacovich R, Espinoza LR (2004) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 17(2):348-369 (Pubitemid 38534032)
20. Corso J, Lugert R, Groß U, Zautner AE (2011) Is the Campylobacter jejuni secretory protein Cj0069 a suitable antigen for serodiagnostics? Eur J Microbiol Immunol 1(1):86-94
21. Schmidt-Ott R, Schmidt H, Feldmann S, Brass F, Krone B, Groß U (2006) Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barre syndrome. Clin Vaccine Immunol: CVI 13(7):779-783
22. Schmidt-Ott R, Brass F, Scholz C, Werner C, Groß U (2005) Improved serodiagnosis of Campylobacter jejuni infections using recombinant antigens. J Med Microbiol 54(Pt 8):761-767 (Pubitemid 41129171)
23. Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP (1993) The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders. Ann Neurol 34(2):136-144 (Pubitemid 23223040)
24. Maeland JA, Bevanger L, Enge J (1993) Serological testing for campylobacteriosis with sera forwarded for Salmonella and Yersinia serology. APMIS: Acta Pathol Microbiol Immunol Scand 101(8):647-650 (Pubitemid 23316791)
25. Strid MA, Engberg J, Larsen LB, Begtrup K, Molbak K, Krogfelt KA (2001) Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients. Clin Diagn Lab Immunol 8(2):314-319 (Pubitemid 32217062)
26. Blaser MJ, Duncan DJ (1984) Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun 44(2):292-298 (Pubitemid 14139793)
27. Blaser MJ, Hopkins JA, Vasil ML (1984) Campylobacter jejuni outer membrane proteins are antigenic for humans. Infect Immun 43(3): 986-993 (Pubitemid 14192820)
28. Burnens A, Stucki U, Nicolet J, Frey J (1995) Identification and characterization of an immunogenic outer membrane protein of Campylobacter jejuni. J Clin Microbiol 33(11):2826-2832
29. Pei ZH, Ellison RT 3rd, Blaser MJ (1991) Identification, purification, and characterization of major antigenic proteins of Campylobacter jejuni. J Biol Chem 266(25):16363-16369 (Pubitemid 21907805)
30. Sopwith W, Birtles A, Matthews M, Fox A, Gee S, Painter M, Regan M, Syed Q, Bolton E (2008) Identification of potential environmentally adapted Campylobacter jejuni strain, United Kingdom. Emerg Infect Dis 14(11):1769-1773
31. Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins RP (1988) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51(5):613-618
32. Rees JH, Soudain SE, Gregson NA, Hughes RA (1995) Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med 333(21):1374-1379
33. Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meche FG (1996) Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann Neurol 40(2):181-187
34. Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H, Saida K (1998) Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 81(1-2):116-126 (Pubitemid 28248191)
35. Cover TL, Aber RC (1989) Yersinia enterocolitica. N Engl J Med 321(1):16-24 (Pubitemid 19170380)
36. Bottone EJ (1997) Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 10(2):257-276
37. Stecher B, Chaffron S, Kappeli R, Hapfelmeier S, Freedrich S, Weber TC, Kirundi J, Suar M, McCoy KD, von Mering C, Macpherson AJ, Hardt WD (2010) Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PloS Pathog 6(1):e1000711
38. Stecher B, Hardt WD (2011) Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol 14(1):82-91
39. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt WD (2007) Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5(10):2177-2189 (Pubitemid 350035420)
40. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Gobel UB, Liesenfeld O (2006) Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 177(12):8785-8795 (Pubitemid 44893845)
41. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, Liesenfeld O, Schumann RR, Gobel UB, Bereswill S (2007) Exacerbation ofmurine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56(7):941-948 (Pubitemid 46999077)
42. Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, Jahn HK, Freudenberg M, Loddenkemper C, Batra A, Lehr HA, Liesenfeld O, Blaut M, Gobel UB, Schumann RR, Bereswill S (2007) Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS ONE 2(7):e662
43. Wohlgemuth S, Keller S, Kertscher R, Stadion M, Haller D, Kisling S, Jahreis G, Blaut M, Loh G (2011) Intestinal steroid profiles and microbiota composition in colitic mice. Gut Microbes 2(3):159-166
44. Haag LM, Fischer A, Otto B, Plickert R, Kühl AA, Gobel UB, Bereswill S, Heimesaat MM (2012) Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS ONE 7(5):e35988
45. Kalischuk LD, Buret AG (2010) A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Am J Physiol Gastrointest Liver Physiol 298(1):G1-G9
46. Man SM, Kaakoush NO, Mitchell HM (2011) The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol 8(3):152-168
47. Helms M, Simonsen J, Molbak K (2006) Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis: Off Publ Infect Dis Soc Am 42(4):498-506 (Pubitemid 43202522)
48. Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol 61(1):1-14